148 related articles for article (PubMed ID: 176753)
1. Effect of chilling on platelet cyclic adenosine 3:5-monophosphate and adenylate cyclase activity.
Zappia GC; Steiner M; Ando Y; Baldini M
Transfusion; 1976; 16(2):122-9. PubMed ID: 176753
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of adenylate cyclase by adenosine analogues in preparations of broken and intact human platelets. Evidence for the unidirectional control of platelet function by cyclic AMP.
Haslam RJ; Davidson MM; Desjardins JV
Biochem J; 1978 Oct; 176(1):83-95. PubMed ID: 215136
[TBL] [Abstract][Full Text] [Related]
3. Stimulation of human platelet adenylate cyclase by prostaglandin D2.
Mills DC; Macfarlane DE
Thromb Res; 1974 Sep; 5(3):401-12. PubMed ID: 4373870
[No Abstract] [Full Text] [Related]
4. Thrombin-induced increase in intracellular cyclic 3',5'-adenosine monophosphate in human platelets.
Droller MJ; Wolfe SM
J Clin Invest; 1972 Dec; 51(12):3094-103. PubMed ID: 4344994
[TBL] [Abstract][Full Text] [Related]
5. Cyclic 3',5'-adenosine monophosphate level and adenylate cyclase activity in human blood platelets during storage in ACD solution.
Lammerant-Guillemare E; Corcelle-Cerf F; Lammerant J
Blut; 1977 Apr; 34(4):329-32. PubMed ID: 192396
[TBL] [Abstract][Full Text] [Related]
6. Calcium-dependent proteolytic stimulation of adenylate cyclase in platelets from spontaneously hypertensive rats.
Tremblay J; Hamet P
Metabolism; 1984 Aug; 33(8):689-95. PubMed ID: 6087083
[TBL] [Abstract][Full Text] [Related]
7. Synergistic interaction of adenylate cyclase activators and nitric oxide donor SIN-1 on platelet cyclic AMP.
Fisch A; Michael-Hepp J; Meyer J; Darius H
Eur J Pharmacol; 1995 May; 289(3):455-61. PubMed ID: 7556414
[TBL] [Abstract][Full Text] [Related]
8. Inhibitory effects of S-(1,2-dicarboxyethyl)glutathione on collagen-induced platelet aggregation; enhancements of cyclic AMP level and adenylate cyclase activity in platelets by S-(1,2-dicarboxyethyl)glutathione.
Tsuboi S; Fujiwara E; Ogata K; Sakaue A; Nakayama T; Ohmori S
Biol Pharm Bull; 1993 Nov; 16(11):1083-6. PubMed ID: 8312859
[TBL] [Abstract][Full Text] [Related]
9. Activation of adenylate cyclase in human platelet membranes by guanosine 5'-[beta gamma-imido]triphosphate is inhibited by cyclic-AMP-dependent phosphorylation. Slow activation occurs in the absence of ATP.
Farndale RW; Wong SK; Martin BR
Biochem J; 1987 Mar; 242(3):637-43. PubMed ID: 3036096
[TBL] [Abstract][Full Text] [Related]
10. Requirement for guanosine triphosphate in the prostaglandin activation of adenylate cyclase of platelet membranes.
Krishna G; Harwood JP
J Biol Chem; 1972 Apr; 247(7):2253-4. PubMed ID: 4335870
[No Abstract] [Full Text] [Related]
11. Interrelationship between adenylate cyclase activity, adenosine 3':5' cyclic monophosphate phosphodiesterase activity, adenosine 3':5' cyclic monophosphate levels, and growth of cells in culture.
Anderson WB; Russell TR; Carchman RA; Pastan I
Proc Natl Acad Sci U S A; 1973 Dec; 70(12):3802-5. PubMed ID: 4359490
[TBL] [Abstract][Full Text] [Related]
12. Correlation between adenosine 3',5'-cyclic monosphosphate levels, adenylate cyclase activity, and adenosine 3',5'-cyclic monophosphate phosphodiesterase activity in tissue culture cells stimulated by serum.
Matsumoto T; Uchida T
J Biochem; 1975 Oct; 78(4):811-5. PubMed ID: 175046
[TBL] [Abstract][Full Text] [Related]
13. Cyclic nucleotides and platelet aggregation. Effect of aggregating agents on the activity of cyclic nucleotide-metabolizing enzymes.
Barber AJ
Biochim Biophys Acta; 1976 Sep; 444(2):579-95. PubMed ID: 9149
[TBL] [Abstract][Full Text] [Related]
14. Determination of the turn-off reaction for the epinephrine-inhibited human platelet adenylate cyclase.
Jakobs KH
Eur J Biochem; 1983 Apr; 132(1):125-30. PubMed ID: 6301820
[TBL] [Abstract][Full Text] [Related]
15. Molecular basis of the synergistic inhibition of platelet function by nitrovasodilators and activators of adenylate cyclase: inhibition of cyclic AMP breakdown by cyclic GMP.
Maurice DH; Haslam RJ
Mol Pharmacol; 1990 May; 37(5):671-81. PubMed ID: 2160060
[TBL] [Abstract][Full Text] [Related]
16. Mode of action of ticlopidine in inhibition of platelet aggregation in the rat.
Ashida SI; Abiko Y
Thromb Haemost; 1979 Apr; 41(2):436-49. PubMed ID: 224522
[TBL] [Abstract][Full Text] [Related]
17. Octimibate inhibition of platelet aggregation: stimulation of adenylate cyclase through prostacyclin receptor activation.
Seiler S; Brassard CL; Arnold AJ; Meanwell NA; Fleming JS; Keely SL
J Pharmacol Exp Ther; 1990 Dec; 255(3):1021-6. PubMed ID: 2175792
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of prostaglandin E1-induced activation of adenylate cyclase in human blood platelet membrane.
Kahn NN; Sinha AK
Biochim Biophys Acta; 1988 Oct; 972(1):45-53. PubMed ID: 2902882
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of prostaglandin E1-responsive platelet adenylate cyclase by heparin: a study of the mechanism of inhibition and its relevance to platelet aggregation.
Amirrasooli H; Mac Neil S; Tomlinson S
Br J Pharmacol; 1981 Jul; 73(3):639-47. PubMed ID: 7248663
[TBL] [Abstract][Full Text] [Related]
20. Effect of acute methadone withdrawal on prostaglandin E-stimulated 3H-cyclic adenosine monophosphate accumulation in human platelets.
Pandey GN; DeLeon-Jones FA; Inwang EE; Davis JM
Clin Pharmacol Ther; 1980 May; 27(5):607-11. PubMed ID: 6245830
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
